FL S1094

Expands the definition of "practice of the profession of pharmacy" to include initiating, modifying, or discontinuing drug therapy for chronic health conditions under collaborative pharmacy practice agreements with physicians

Creates a new framework allowing pharmacists to manage patients with specific chronic conditions (arthritis, asthma, COPD, Type 2 diabetes, HIV/AIDS, and obesity) through collaborative practice agreements with licensed physicians

Requires pharmacists entering collaborative practice agreements to hold a doctor of pharmacy degree or have 5 years of experience, complete a 20-hour training course, maintain $250,000 in liability insurance, and complete 8 hours of continuing education every 2 years

Authorizes consultant pharmacists working in health care facilities (hospitals, nursing homes, hospices, ambulatory surgical centers) to order and evaluate laboratory tests, conduct patient assessments, and modify or discontinue medications under written collaborative agreements with physicians

Prohibits pharmacists from initiating or prescribing controlled substances under collaborative agreements and requires agreements to be filed with the Board of Pharmacy before implementation, with renewal required every 2 years